- Home
- PTGX vs RGTI Comparison
PTGX vs RGTI Comparison
Compare PTGX & RGTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- RGTI
- Stock Information
- Founded
- PTGX 2006
- RGTI 2013
- Country
- PTGX United States
- RGTI United States
- Employees
- PTGX N/A
- RGTI N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- RGTI Retail: Computer Software & Peripheral Equipment
- Sector
- PTGX Health Care
- RGTI Technology
- Exchange
- PTGX Nasdaq
- RGTI Nasdaq
- Market Cap
- PTGX 3.3B
- RGTI 3.5B
- IPO Year
- PTGX 2016
- RGTI N/A
- Fundamental
- Price
- PTGX $55.23
- RGTI $12.77
- Analyst Decision
- PTGX Strong Buy
- RGTI Strong Buy
- Analyst Count
- PTGX 9
- RGTI 5
- Target Price
- PTGX $67.11
- RGTI $14.20
- AVG Volume (30 Days)
- PTGX 925.2K
- RGTI 36.6M
- Earning Date
- PTGX 08-05-2025
- RGTI 08-07-2025
- Dividend Yield
- PTGX N/A
- RGTI N/A
- EPS Growth
- PTGX N/A
- RGTI N/A
- EPS
- PTGX 0.86
- RGTI N/A
- Revenue
- PTGX $207,801,000.00
- RGTI $9,210,000.00
- Revenue This Year
- PTGX N/A
- RGTI N/A
- Revenue Next Year
- PTGX $53.09
- RGTI $160.90
- P/E Ratio
- PTGX $63.67
- RGTI N/A
- Revenue Growth
- PTGX N/A
- RGTI N/A
- 52 Week Low
- PTGX $32.50
- RGTI $0.66
- 52 Week High
- PTGX $60.60
- RGTI $21.42
- Technical
- Relative Strength Index (RSI)
- PTGX 60.92
- RGTI 54.32
- Support Level
- PTGX $49.38
- RGTI $12.08
- Resistance Level
- PTGX $51.51
- RGTI $14.24
- Average True Range (ATR)
- PTGX 2.09
- RGTI 0.87
- MACD
- PTGX -0.14
- RGTI 0.06
- Stochastic Oscillator
- PTGX 74.47
- RGTI 57.27
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About RGTI Rigetti Computing Inc.
Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.